AI Model Predicts Inpatient Surgical Discharges
The machine-learning model could be used to increase timeliness of discharges, investigators suggested.
Related Articles
Time-Restricted Eating Shows Promise for Metabolic Syndrome in 3-Month Trial
Time-restricted eating, even without calorie restriction, improved glycemic control and cardiometabolic health in patients with metabolic syndrome.
Embracing New Therapies in Schizophrenia Management: Introductions
In part 1 of 5, panel moderator gives an overview of the Special Report focusing on the approval of Xanomeline and tropism chloride capsules for…
Allergy Month in Review: September 2024
In the allergy news space, this Month in Review highlights some of the most significant stories covered by the editorial team.
FDA Grants Breakthrough Therapy Designation to Survodutide for Noncirrhotic MASH
In addition to the Breakthrough Therapy Designation, Boehringer Ingelheim announced the initiation of 2 phase 3 trials in adults with MASH and fibrosis and compensated…
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Mease discussed the importance of comparator studies in a growing treatment landscape for PsA.
FDA Grants Breakthrough Therapy Designation to Survodutide for Noncirrhotic MASH
In addition to the Breakthrough Therapy Designation, Boehringer Ingelheim announced the initiation of 2 phase 3 trials in adults with MASH and fibrosis and compensated…
Anemia May Worsen Prognosis of Primary Care Patients with Heart Failure
Anemia is frequently observed in primary care patients with HF and is linked to worse prognosis and comorbidities, including cancer.
Clinical Quiz: MAESTRO-NASH Trial Procedures for Resmetirom in MASH
Test your knowledge of the phase 3 MAESTRO-NASH trial supporting resmetirom (Rezdiffra)’s FDA accelerated approval for MASH with this quiz.
Secukinumab Surpasses Ustekinumab in Clearing Skin for Generalized Pustular Psoriasis
A study shows secukinumab clears skin lesions faster than ustekinumab in generalized pustular psoriasis, with improved responses observed by week 2.
The APAC Recap: RhAPP 5th Annual National Conference, with Laura Ross, PA-C
APAC President Laura Ross, PA-C, shares insights from the RhAPP conference, discussing autoimmune disease, cardiovascular risks, and the importance of interdisciplinary care.